Delayed Neurological Paraneoplastic Syndrome from a Breast Carcinoma: A Case Report
Abstract
Paraneoplastic neurological syndromes are a group of rare disorders triggered by an abnormal immune system response to a cancerous tumour. A woman with a breast carcinoma underwent neoadjuvant chemotherapy. This was followed by surgery, radiotherapy and endocrine therapy. Her co-morbidities were hypertension and diabetes mellitus. Eighteen months later, she presented with an acute onset of back pain with bilateral lower limb paraparesis. She had fever for 2 weeks prior to this. She was unable to walk and was confined to a wheelchair. She was anaemic with a haemoglobin of 7.3 g%. Spinal magnetic resonance imaging could not find any metastases. Cerebrospinal fluid analysis showed mild pleocytosis and absence of infection and malignancy. Whole body positron emission tomography computed tomography scan did not find any increased metabolic activity. Nerve conduction study showed electrophysiological evidence of generalised sensorimotor axonal polyneuropathy and bilateral subacute-chronic lumbosacral plexopathy. A paraneoplastic antigen autoimmune profile showed that the anti-amphiphysin was at borderline level. She was diagnosed to have neurological paraneoplastic syndrome and given intravenous methylprednisolone and immunoglobulin. Her lower limb weakness gradually improved. This case highlights the importance of recognising paraneoplastic markers like anti-amphiphysin in patients with breast cancer presenting with atypical, symmetric proximal weakness.
Keywords
Full Text:
PDFReferences
Oppenheim H. Über Hirnsymptome bei Carcinomatose ohne nachweisbare Veränderungen im Gehirn. Charité-Annalen 1888; 13: 335-344.
Guichard A, Vignon G. La Polyradiculonéurite cancéreuse métastatique. J Med Lyon. 1949; 30: 197-207.
Baijens LW, Manni JJ. Paraneoplastic syndromes in patients with primary malignancies of the head and neck: Four cases and a review of the literature. Eur Arch Otorhinolaryngol 2006; 263: 32-6. https://doi.org/10.1007/s00405-005-0942-1
Pelosof LC, Gerber DE. Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment. Mayo Clin Proc 2010; 85(9): 838-54. https://doi.org/10.4065/mcp.2010.0099
Fanous I, Dillon P. Paraneoplastic neurological complications of breast cancer. Exp Hematol Oncol 2016; 5: 29. https://doi.org/10.1186/s40164-016-0058-x
Ezat SW, Syed Junid SM, Noraziani K et al. Skeletal-related events among breast and prostate cancer patients: Towards new treatment initiation in Malaysia's hospital setting. Asian Pac J Cancer Prev 2013; 14(5), 3357-62. https://doi.org/10.7314/apjcp.2013.14.5.3357
Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006; 12(20 Pt 2): 6243s-9s. https://doi.org/10.1158/1078-0432.CCR-06-0931
Himani. Diabetes-induced paralysis: Understanding and treatment options. Diabetes Mantra. 2025. https://diabetesmantra.com/diabetes/treatment/diabetes-paralysis-treatment/ [Accessed on 24 August 2025]
Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003; 349(16): 1543-54. https://doi.org/10.1056/NEJMra023009
Rojas-Marcos I, Rousseau A, Keime-Guibert F. et al. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer. Medicine 2003; 82(3): 216-23. https://doi.org/10.1097/01.md.0000076004.64510.ce
Youssef J, Novosad SA, Winthrop KL. Infection risk and safety of corticosteroid use. Rheum Dis Clin North Am 2016; 42(1): 157-76, ix-x. https://doi.org/10.1016/j.rdc.2015.08.004
Carey IM, Critchley JA, De Wilde S, Harris T, Hosking FJ, Cook DG. Risk of infection in Type 1 and Type 2 Diabetes compared with the general population: A matched cohort study. Diabetes Care 2018; 41(3): 513-21. https://doi.org/10.2337/dc17-2131
DOI: http://dx.doi.org/10.17576/JSA.2026.1602.03
Refbacks
- There are currently no refbacks.
e-issn 2231-7481